143 related articles for article (PubMed ID: 12372062)
1. Analysis of the two common alpha-1-antitrypsin deficiency alleles PiMS and PiMZ as modifiers of Pseudomonas aeruginosa susceptibility in cystic fibrosis.
Meyer P; Braun A; Roscher AA
Clin Genet; 2002 Oct; 62(4):325-7. PubMed ID: 12372062
[TBL] [Abstract][Full Text] [Related]
2. Alpha1-antitrypsin deficiency alleles and the Taq-I G-->A allele in cystic fibrosis lung disease.
Mahadeva R; Westerbeek RC; Perry DJ; Lovegrove JU; Whitehouse DB; Carroll NR; Ross-Russell RI; Webb AK; Bilton D; Lomas DA
Eur Respir J; 1998 Apr; 11(4):873-9. PubMed ID: 9623690
[TBL] [Abstract][Full Text] [Related]
3. Phenotypes and serum level of alpha-1-antitrypsin in lung cancer.
Topic A; Ljujic M; Petrovic-Stanojevic N; Dopudja-Pantic V; Radojkovic D
J BUON; 2011; 16(4):672-6. PubMed ID: 22331720
[TBL] [Abstract][Full Text] [Related]
4. Alpha 1-antitrypsin deficiency alleles in cystic fibrosis lung disease.
Frangolias DD; Ruan J; Wilcox PJ; Davidson AG; Wong LT; Berthiaume Y; Hennessey R; Freitag A; Pedder L; Corey M; Sweezey N; Zielenski J; Tullis E; Sandford AJ
Am J Respir Cell Mol Biol; 2003 Sep; 29(3 Pt 1):390-6. PubMed ID: 12689922
[TBL] [Abstract][Full Text] [Related]
5. Alpha-1 antitrypsin deficiency is not a rare disease but a disease that is rarely diagnosed.
de Serres FJ
Environ Health Perspect; 2003 Dec; 111(16):1851-4. PubMed ID: 14654440
[TBL] [Abstract][Full Text] [Related]
6. SERPINA1 PiZ and PiS heterozygotes and lung function decline in the SAPALDIA cohort.
Thun GA; Ferrarotti I; Imboden M; Rochat T; Gerbase M; Kronenberg F; Bridevaux PO; Zemp E; Zorzetto M; Ottaviani S; Russi EW; Luisetti M; Probst-Hensch NM
PLoS One; 2012; 7(8):e42728. PubMed ID: 22912729
[TBL] [Abstract][Full Text] [Related]
7. Serine protease inhibitors in patients with chronic viral hepatitis.
Elzouki AN; Verbaan H; Lindgren S; Widell A; Carlson J; Eriksson S
J Hepatol; 1997 Jul; 27(1):42-8. PubMed ID: 9252072
[TBL] [Abstract][Full Text] [Related]
8. An alpha1-antitrypsin enhancer polymorphism is a genetic modifier of pulmonary outcome in cystic fibrosis.
Henry MT; Cave S; Rendall J; O'Connor CM; Morgan K; FitzGerald MX; Kalsheker N
Eur J Hum Genet; 2001 Apr; 9(4):273-8. PubMed ID: 11313771
[TBL] [Abstract][Full Text] [Related]
9. Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha(1)-antitrypsin deficiency (PiZ).
Hill AT; Campbell EJ; Bayley DL; Hill SL; Stockley RA
Am J Respir Crit Care Med; 1999 Dec; 160(6):1968-75. PubMed ID: 10588615
[TBL] [Abstract][Full Text] [Related]
10. Alleles of the alpha-1-antitrypsin phenotype in patients with aortic aneurysms.
Schardey HM; Hernandez-Richter T; Klueppelberg U; Tutsch-Bauer E; Lauterjung L
J Cardiovasc Surg (Torino); 1998 Oct; 39(5):535-9. PubMed ID: 9833707
[TBL] [Abstract][Full Text] [Related]
11. Retrospective analysis of children with α-1 antitrypsin deficiency.
Comba A; Demirbaş F; Çaltepe G; Eren E; Kalayci AG
Eur J Gastroenterol Hepatol; 2018 Jul; 30(7):774-778. PubMed ID: 29505478
[TBL] [Abstract][Full Text] [Related]
12. Estimating the risk for alpha-1 antitrypsin deficiency among COPD patients: evidence supporting targeted screening.
de Serres FJ; Blanco I; Fernández-Bustillo E
COPD; 2006 Aug; 3(3):133-9. PubMed ID: 17240615
[TBL] [Abstract][Full Text] [Related]
13. Allotypes of alpha 1-antitrypsin in patients with cystic fibrosis, homozygous and heterozygous for deltaF508.
Döring G; Krogh-Johansen H; Weidinger S; Høiby N
Pediatr Pulmonol; 1994 Jul; 18(1):3-7. PubMed ID: 7970905
[TBL] [Abstract][Full Text] [Related]
14. [Usefulness of the quantification of the alpha-1 serous protein band in the screening of alpha-1-antitrypsin deficiency].
Miravitlles M; Jardí R; Rodríguez-Frías F; Torrella M; Pelegrí D; Vidal R
Arch Bronconeumol; 1998 Dec; 34(11):536-40. PubMed ID: 9929722
[TBL] [Abstract][Full Text] [Related]
15. Genetic epidemiology of alpha-1 antitrypsin deficiency in North America and Australia/New Zealand: Australia, Canada, New Zealand and the United States of America.
de Serres FJ; Blanco I; Fernández-Bustillo E
Clin Genet; 2003 Nov; 64(5):382-97. PubMed ID: 14616761
[TBL] [Abstract][Full Text] [Related]
16. Alpha-1 antitrypsin deficiency alleles and severe cystic fibrosis lung disease.
Mahadeva R; Stewart S; Bilton D; Lomas DA
Thorax; 1998 Dec; 53(12):1022-4. PubMed ID: 10195072
[TBL] [Abstract][Full Text] [Related]
17. Α₁-antitrypsin PiMZ heterozygosity has an independent aggravating effect on liver fibrosis in alcoholic liver disease.
Goltz D; Hittetiya K; Vössing LM; Kirfel J; Spengler U; Fischer HP
Virchows Arch; 2014 Nov; 465(5):539-46. PubMed ID: 25070245
[TBL] [Abstract][Full Text] [Related]
18. Genetic epidemiology of alpha-1 antitrypsin deficiency in southern Europe: France, Italy, Portugal and Spain.
de Serres FJ; Blanco I; Fernández-Bustillo E
Clin Genet; 2003 Jun; 63(6):490-509. PubMed ID: 12786756
[TBL] [Abstract][Full Text] [Related]
19. Alpha-1-antitrypsin phenotypes and associated disease patterns in neurological patients.
Lolin YI; Ward AM
Acta Neurol Scand; 1995 May; 91(5):394-8. PubMed ID: 7639071
[TBL] [Abstract][Full Text] [Related]
20. Worldwide racial and ethnic distribution of alpha1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys.
de Serres FJ
Chest; 2002 Nov; 122(5):1818-29. PubMed ID: 12426287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
